Ubs Oconnor LLC Bio Xcel Therapeutics, Inc. Transaction History

Ubs Oconnor LLC

  • $1.44 Billion
  • Q1 2025

A detailed history of Ubs Oconnor LLC transactions in Bio Xcel Therapeutics, Inc. stock. As of the latest transaction made, Ubs Oconnor LLC holds 16,000 shares of BTAI stock, worth $22,400. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,000
Holding current value
$22,400
% of portfolio
0.0%

Shares

0 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
No transaction found.

Others Institutions Holding BTAI

# of Institutions
3
Shares Held
445K
Call Options Held
0
Put Options Held
0
View Full List

About BioXcel Therapeutics, Inc.

BTAI Quotes by TradingView
  • Ticker BTAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,022,500
  • Market Cap $39.2M
  • Description
  • BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...
More about BTAI
Track This Portfolio

Track Ubs Oconnor LLC Portfolio

Follow Ubs Oconnor LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Oconnor LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Oconnor LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email